Atlas Trials

The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance

Clinical trial NCT04831047 · COMPLETED

Trial details

NCT number
NCT04831047
Sponsor
University of Miami
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Ptosis, EyelidConjunctiva InflamedEye Manifestations
Start date
2021-06-08
Primary completion
2022-04-01
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.